- BioAge Labs, Inc. press release (NASDAQ:BIOA): GAAP EPS of -$6.70.
- As of September 30, 2024, BioAge had approximately $334.5 million in cash and cash equivalents.
More on BioAge Labs, Inc.
- BioAge Labs: Weighing The Risks And Rewards Of A Biotech Revival
- BioAge Labs Readies $100 Million IPO Plan For Obesity Treatment
- Goldman Sachs, Morgan Stanley bullish on BioAge, cite Lilly relationship
- Regeneron co-founder warns of harms from weight-loss drugs: FT
- Historical earnings data for BioAge Labs, Inc.